Palm Beach Gardens, Florida-based Accelus, a company focused on accelerating minimally invasive spine surgery, has announced the appointment of three of its team members to executive sales positions.
Accelus Announces Executive Sales Team
2 min read Premium comments
#accelusSecondary#jayshellhammer#jimfox#lisajacobs
The promotions on its sales team include Lisa Jacobs to vice president of sales, Jim Fox to East U.S. vice president of sales, and Jay Shellhammer to West U.S. vice president of sales. OTW spoke with all three sales leaders about their new appointments.
Jacobs has a long history of sales success. Prior to joining Integrity Implants (which is now Accelus) as national director of minimally invasive spine surgery, Jacobs held various sales leadership positions at joimax, Medacta, Zimmer Biomet, and LDR. She obtained a Master of Science degree from Northeastern University and a Bachelor of Science degree from Boston College.
Jacobs told OTW, “We have assembled an exceptional team of talented spine industry leaders who are already transforming the business at Accelus. Together with our internal sales team, clinical team and distribution partners, we are building momentum through our robotic navigation platform and innovative product portfolio.”
Jacobs continued, “I am extremely bullish with the organizational direction and confident we have what it takes to distinguish ourselves from the pack. This new sales team structure will better position Accelus to fulfill our commitments to patients, surgeons and employees and drive Accelus’s success through sustainable growth.”
Fox also joined Accelus when it was Integrity Implants. He joined as an area sales director in 2019. Prior to joining the team, Fox held leadership positions at several companies including Benvenue Medical, Safe Passage Neuromonitoring, Biomet, and Medtronic. He has also offered orthopedic and neurosurgery consulting services for a number of years. Fox received his Bachelor of Science in Sports Medicine/Athletic Training from Syracuse University.
Fox said, “I am excited to represent our growing sales team at Accelus. Since arriving almost three years ago with Integrity Implants (now Accelus), the interest and adoption of our multidirectional expandable TLIF (FlareHawk®) has been so energizing and rewarding.”
“The addition of the Remi™ Robotic Navigation platform further leverages our value-added position, especially as more spinal surgeries are performed in the outpatient setting. I am honored to work with our dynamic sales team and inspired to represent them every day.”
Shellhammer joined Accelus last year as an area sales director. Prior to joining Accelus, Shellhammer amassed more than 20 years of medical sales and leadership experience at numerous companies including Zimmer Biomet Spine, Stryker Spine, Ethicon, and Intuitive Surgical Ltd.
Shellhammer said, “Accelus has quickly become the most exciting and innovative spine company to enter the market over the last decade. With the accelerated growth of FlareHawk, being adopted by some of the most thought leading and respected surgeons in the world, to our latest innovative technologies in robotics and lateral procedures, I am honored and excited to be leading our sales team in the West.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.